Salvia is a young innovative start-up company active in the emerging field of “BioElectronics” that is inspired by biology and electronics to provide innovative therapeutic solutions. The name Salvia is derived from the Latin word salvere, which means "to stay healthy". We are driven to deliver bioelectronic solutions that restore health for people suffering from severe neurologic disorders; our ambition is to make these novel therapies widely accessible.
The Salvia team consists of experienced entrepreneurs, engineers and scientists with diverse professional backgrounds and proven track-record throughout the medical device industry (Sapiens, Medtronic, Philips, St Jude, BioSensors International, Kyphon, etc).
The human body is controlled by patterns of electrical impulses transmitted through nerve fibers. In chronic disease, these electrical patterns are different.
Bioelectronics are smart devices that use mild electrical impulses to influence nerve activity. Electrical stimulation is nothing new – cardiac pacemakers have been in use for decades – but scientists are just beginning to realize the possibilities of regulating nerve signals to actually treat disease.
Only great teams make lasting impacts…
At Salvia we are always interested in getting to know highly motivated and talented individuals to strengthen our R&D team.
Whether you are an experienced professional, an intern, or you're just starting your career, feel free to contact us if you aspire to make an impact to the Bioelectronics field.
Senior Mechanical Design Engineer
Click here to apply.
Acquisition is not appreciated.
2018 – Gerard & Anton award
: Salvia BioElectronics received the Gerard & Anton Award – named after the founders of Philips – recognizing Salvia as one of the 10 most promising startups-to-watch in the Brainport Eindhoven region.
2018 – POSITION-II project kick-off
: Salvia BioElectronics B.V. joined this 3-year collaborative project, in which partners from 12 European countries join forces to develop the next generation smart catheters and implants. The project received funding from the ECSEL Joint Undertaking in collaboration with the European Union's H2020 programme.
2018 – TEDx talk
: “A call for Humane Technology” by Salvia founder Michel Decre.
2018 – Press release
: Eindhoven start-up Salvia BioElectronics B.V. announced today that it secured € 1.3 million in seed funding to develop a minimally invasive bioelectronics solution for people suffering from chronic neurological disease. The funding is provided by a syndicate led by the Brabant Development Agency (BOM) and Thuja Capital Healthcare Seed Fund II, and includes the Netherlands Enterprise Agency (RVO.nl) and founders and employees of Salvia.
Salvia BioElectronics is located at the High Tech Campus building 41.
High Tech Campus Eindhoven is the smartest square km in Europe with more than 150 companies and 10.000 people working there.
A map of the High Tech Campus is also available here